endorsed by

LEAD Sponsor





About Baxter

Every day, millions of patients, caregivers and providers around the world rely on Baxter’s leading portfolio of diagnostic, critical care, nutrition, kidney care, hospital and surgical products and solutions. For 90 years, we’ve been making an impact at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. 

With products, therapies and digital health solutions available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.

To learn more, visit www.baxter.com and follow us on  Twitter and LinkedIn.


DIAMOND Sponsor








About Fresenius Medical Care

Fresenius Medical Care is the world's leading provider of products and services for individuals with renal diseases of which around 4.1 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,757 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approx. 311,000 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. 

To learn more, visit us on https://www.freseniusmedicalcare.com/en/home and follow us on Facebook and LinkedIn.



SILVER Sponsors


About GulfDrug

GulfDrug's Pharmaceuticals division stands as a cornerstone in the provision of comprehensive pharmaceuticals, over-the-counter (OTC) and consumer health products sourced from world-class manufacturers and renowned brands. 

As a trusted pharmaceutical agent and distributor for leading multinational enterprises, we specialize in delivering innovative healthcare solutions in UAE.







About WEGO

WEGO Blood Purification business group was founded in 2004. With the development of 20 years, now we are the largest blood purification product manufacturer and service provider in China.

We have 7 subsidiaries, two of which are joint ventures. One is WEGO-NIKKISO, which is focused on the manufacture of dialysis machines and the other is WEGO-TERUMO, which is specialized in producing peritoneal dialysis products. 

We have nearly 100 dialysis clinics in China and almost all the products are manufactured by our own.  As for dialyzers, we have 13 spinning and assembly production lines and the annual production capacity can reach 65 million. Since 2018, our dialyzer market share has always been ranked 1st in China.

For more information, please kindly visit our official website: www.wego-healthcare.com/en


EXHIBITORS


           

About InBody Co., Ltd.

InBody is one of the worldwide leaders in body composition technology. Non-invasive, fast and with little effort, InBody provides a comprehensive overview of a person’s overall health. 

           

 

           

About Kriba

Kriba® is a medical device startup that generates impact in healthcare by facilitating non-invasive screening, detection, and monitoring of serous body fluids infections.

Neosonics® Vitro Kidney is an automatic, compact, quick, easy-to-use device that non-invasively determines effluent elevated white blood cell levels and differential on the drainage bag. Neosonics Vitro Kidney can support clinical decision-making for early detection and prevention of peritonitis complications.

  

           

 



           

 





           

About Triomed

Triomed is developing innovative systems to address the key limitations of Peritoneal Dialysis. Systems to ensure that Peritoneal Dialysis becomes the preferred dialysis alternative for End-Stage Kidney Disease patients, and help patients stay on Peritoneal Dialysis longer

By continually recirculating and regenerating dialysate fluid, Triomed SCPD maintains a constant osmotic gradient over the patient’s peritoneal membrane, something traditional Peritoneal Dialysis does not do.

Award winning clinical studies have shown that Triomed SCPD leads to a significant increase in the removal of water and salt from Peritoneal Dialysis patients and a significant improvement in glucose efficiency.

  

 FOR MORE INFORMATION:

    www.ispd.org/dubai2024 
   info@ispd2024.com 
   @ISPDcongress